在COVID-19后,爱斯坦-巴尔病毒 (EBV) 的重新激活
Eslam Farid Abu Shady1, Abdelhakim Fouad Ghallab1, Doaa Abdullah Shaker2
1Otorhinolaryngology Department, Faculty of Medicine, Benha University, Benha, Qalyubia, Egypt.
Auris, nasus, larynx
|June 27, 2025
概括
爱斯坦-巴尔病毒 (EBV) 的重新激活与长期COVID症状如疲劳有关. 这表明EBV抑制剂可能有助于治疗COVID后持续的疾病.
科学领域:
- 病毒学 病毒学
- 传染性疾病 传染性疾病
- 免疫学 免疫学 免疫学
背景情况:
- 长期COVID综合征呈现出SARS-CoV-2感染后的持续症状.
- 爱斯坦-巴尔病毒 (EBV) 是一种常见的疹病毒,以潜伏和重新激活而闻名.
- 病毒再激活在慢性后病毒综合征中的潜在作用仍然是积极研究的领域.
研究的目的:
- 为了研究长期COVID-19症状与爱斯坦-巴尔病毒 (EBV) 再激活之间的关联.
- 为了确定有助于长期COVID综合征发展的潜在风险因素.
主要方法:
- 进行了一项观察性病例控制研究,140名COVID-19患者出现持续症状和80名康复的对照.
- 使用TaqMan探针和特定的原始物来识别EBV遗传物质来检测EBV的重新激活.
- 分析了EBV特异性抗体标位 (EBNA-1 IgG,EA-D IgG) 的情况.
主要成果:
- 在急性COVID-19期间的初次住院和COVID后疲劳之间发现了显著的关联 (p=0.007).
- 在持久性疲劳的患者中,EBV的再激活在28.6%的患者中被观察到,而对照组中则为11.3% (p=0.003).
- 增加的EBV特异性抗体标位 (EBNA-1 IgG,EA-D IgG) 进一步支持EBV的重新激活.
结论:
- 爱斯坦-巴尔病毒的重新激活与长期COVID综合征的发病有关.
- 这些发现支持EBV抑制剂对管理COVID-19后持续症状的潜在治疗益处.
相关概念视频
Cross-reactivity
31.5K
Overview
31.5K
Immunological Memory
5.9K
Immunological memory, a pivotal pillar of the adaptive immune system, is responsible for the body's ability to remember and respond more swiftly and effectively to previously encountered pathogens. This remarkable feature is what makes vaccines so effective in preventing diseases.
What is Immunological Memory?
Immunological memory is an integral function of the immune system that allows it to recognize and react more rapidly and effectively to pathogens previously encountered. This feature...
What is Immunological Memory?
Immunological memory is an integral function of the immune system that allows it to recognize and react more rapidly and effectively to pathogens previously encountered. This feature...
5.9K
Pulmonary Tuberculosis II
381
Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
381
Myocarditis III: Medical Management
18
Myocarditis: Comprehensive Medical ManagementMyocarditis, the heart muscle inflammation, requires a comprehensive medical management strategy that addresses the underlying cause, provides supportive care, manages symptoms, and reduces cardiac workload.Infections and Autoimmune CausesAdminister appropriate antimicrobial therapy when an infectious agent causes myocarditis. For instance, penicillin treats infections caused by Group A Streptococcus. In cases where autoimmune processes are...
18


